🔎 Trials Near Me

Početna › HIV › Georgia

Kliničke studije za HIV u državi Georgia

14 studija za HIV traži sudionike na lokacijama u državi Georgia.

Gradovi u državi Georgia

Službeni tekst studije (engleski)

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

  • Faebris Medical & Community Education, Atlanta
  • Grady Memorial Hospital, Atlanta
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07473778

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

  • GSK Investigational Site, Decatur
U tijeku regrutacijaFaza 3
Od 12 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07650916

A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)

  • Metro Infectious Diseases Consultants L.L.C. ( Site 1509), Decatur
  • Mercer university, Department of internal medicine-Clinical Research ( Site 1512), Macon
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 21. ruj 2026. · NCT07266831

Screen2Prevent (S2P)

  • Emory Atlanta Adolescent Consortium, Atlanta
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 14 do 24 godina · Oba spola · Ažurirano 17. kol 2026. · NCT07728123

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

  • Atlanta ID Group, PC, Atlanta
  • Chatham County Health Department, Savannah
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. kol 2026. · NCT07682961

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

  • GSK Investigational Site, Atlanta
  • GSK Investigational Site, Macon
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 23. srp 2026. · NCT07202546

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

  • Emory Children's Center ( Site 0103), Atlanta
U tijeku regrutacijaFaza 2
4 Weeks – 11 Years · Oba spola · Ažurirano 8. srp 2026. · NCT04375800

Inflammation and Depression in People With HIV

  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital, Atlanta
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 28. svi 2026. · NCT05849038

Menopausal HT for Women Living With HIV (HoT)

  • The Ponce de Leon Center CRS (5802), Atlanta
U tijeku regrutacijaFaza 4
Od 40 do 60 godina · Žene · Ažurirano 22. svi 2026. · NCT06856174

Low Dose Naltrexone for Pain in Patients With HIV

  • Grady Memorial Hospital, Atlanta
  • Emory Midtown Hospital, Atlanta
  • Emory University Hospital, Atlanta
U tijeku regrutacijaFaza 4
Od 18 do 75 godina · Oba spola · Ažurirano 9. tra 2026. · NCT05537935

Baricitinib for Reduction of HIV - CNS

  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital, Atlanta
U tijeku regrutacijaFaza 2
Od 18 do 65 godina · Oba spola · Ažurirano 23. ožu 2026. · NCT05452564

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

  • Ponce de Leon Center CRS, Atlanta
  • The Hope Clinic of the Emory Vaccine Research Center; Emory University, Decatur
U tijeku regrutacijaFaza 1Zdravi dobrovoljci dobrodošli
Od 18 do 55 godina · Oba spola · Ažurirano 25. ruj 2025. · NCT06796686

HIV Treatment Adherence Dose Determination Trial

  • University of Connecticut Field Site, Atlanta
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 29. kol 2025. · NCT04577313

Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics

  • GSK Investigational Site, Atlanta
U tijeku regrutacijaFaza 1/2
Od 6 do 12 godina · Oba spola · Ažurirano 19. ruj 2024. · NCT05674656

Iz ClinicalTrials.gov, podaci preuzeti 4. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.